SLN is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of SLN shares has decreased $0.08 since the market last closed. This is a 1.09% ...
Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...
Eramet is in "very advanced talks" with the French government to remove from its balance sheet several hundred million euros of debt related to its loss-making nickel subsidiary SLN in New Caledonia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results